A team of researchers have found that persons with schizophrenia may have lower levels of certain specific proteins that show up on their brain scans. This could help as diagnostic tools, say experts.

A team of UK researchers has, for the first time in living human brains, demonstrated how the cognitive dysfunction seen in schizophrenia may be caused by the lack of a key protein known to facilitate ...

A multi-institute team led by St. Jude Children's Research Hospital and UT Southwestern Medical Center investigators established for the first time how certain drugs used to treat epilepsy affect ...

A multi-institute team led by St. Jude Children’s Research Hospital and UT Southwestern Medical Center investigators established for the first time how certain drugs used to treat epilepsy affect ...

Washington D.C. [USA], Jan 19 (ANI): People with schizophrenia appear to have decreased levels of a specific protein that is an indicator of the density of synaptic nerve endings. The scientists have ...

PET brain scans showing that 18 healthy volunteers (right) have on average higher levels (shown by yellow-red) of synapse marker protein SV2A than 18 participants with schizophrenia (left). Disclaimer ...

Synapses are the connections between neurons that allow them to communicate with each other. When synapses become compromised and can no longer effectively communicate, they are lost, and brain ...

Early in Alzheimer’s, connections between neurons begin to wither and die. One of the defining features of AD, this synapse loss underlies cognitive impairment, but has proven hard to track in the ...

Plasma tests for Aβ and phospho-tau may have stolen the show at this year’s Alzheimer’s Association International Conference, held July 14-18 in Los Angeles, but proteomic and synaptic markers were ...

Yale researchers at the School of Medicine developed a new imaging technique that measures synaptic activity in patients with Alzheimer’s disease to hopefully link the loss of activity with cognitive ...